Showing 61-70 of 3459 results for "".
Take 5 With Bobak Azamian, MD, PhD, Chief Executive Officer and Chairman of Tarsus Pharmaceuticals
https://practicaldermatology.com/columns/take-5/take-5-with-bobak-azamian-md-phd-chief-executive-officer-and-chairman-of-tarsus-pharmaceuticals/23982/The Landscape for Vitiligo: An Interview with Larry Green, MD
https://practicaldermatology.com/topics/pigmentary-disorders/the-landscape-for-vitiligo-an-interview-with-larry-green-md/24209/Practical Dermatology® Chief Medical Editor Neal Bhatia, MD, FAAD, talked with Larry Green, MD, a board-certified dermatologist in private practice in Rockville, Maryland, about the latest in vitiligo treatment and what practitioners can tell their patients about recent advances in treatment for thiApps To Detect Skin Cancer: Not Ready for Prime Time
https://practicaldermatology.com/topics/skin-cancer-photoprotection/apps-to-detect-skin-cancer-not-ready-for-prime-time/23725/Veronica Rotemberg, MD, PhD discusses the risks of relying on apps to aid in skin cancer diagnosisUnderstanding Sublative Therapy
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/understanding-sublative-therapy/19056/What is sublative? Michael H. Gold, MD explains how the technology works and how it fits in practice.Scale 2023: Exclusive Preview from Music City
https://practicaldermatology.com/topics/practice-management/music-city-sound/20184/Michael Gold, MD, gives a sneak peek of the exciting agenda for the upcoming Music City SCALE 2023 meeting.Minimally Invasive Trends
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/minimally-invasive-trends/19055/Michael H. Gold, MD talks about the latest trends in minimally invasive procedures, including for rejuvenation of the neck.Journal Club: Dupilumab and Atopic March
https://reachmd.com/programs/Practical-Dermatology-Atopic-Dermatitis-Journal-Club/journal-club-dupilumab-and-atopic-march/32405/Practical Dermatology Associate Medical Editor Elizabeth (Lisa) Swanson, MD, FAAD, and Editorial Board member Peter Lio, MD, discuss recent research indicating a reduced risk of atopic march in pediatric atopic dermatitis patients on dupilumab.Lin TL, Fan YH, Fan KS, Juan CK, Chen YJ, Wu CY. ReducedApproval for Evolus; Remembering Vic Narurkar, MD
https://practicaldermatology.com/topics/practice-management/dermwiretv-approval-for-evolus-remembering-vic-narurkar-md/19553/The FDA has approved Jeuveau, the lead product from Evolus, Inc. David Moatazedi, President and CEO of Evolus, and Michael Jafar, Chief Marketing Officer at Evolus, comment on market potential for the new product.Twenty-eight percent of physicians say the prior authorization process required by healMichael Gold Honored, CSF Highlights, Anxiety Linked to Skin Disease
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-michael-gold-honored-csf-highlights-anxiety-linked-to-skin-disease/18720/From bloodless blephs to nutraceuticals, innovative approaches to patient care take the spotlight at Cosmetic Surgery Forum each year. This year, the meeting introduced new topics and new speakers, says CSF founder and Practical Dermatology Chief Cosmetic Surgery Editor, Dr. Joel Schlessinger. Dr. MAcne & Rosacea: 2020 and Beyond
https://practicaldermatology.com/topics/acne-rosacea/acne-rosacea-2020-and-beyond/19734/Guy Webster, MD, PhD reviews developments in acne and rosacea.